Transforming growth factor-β1 and fibrosis in congenital muscular dystrophies
- 1 January 1999
- journal article
- clinical trial
- Published by Elsevier BV in Neuromuscular Disorders
- Vol. 9 (1), 28-33
- https://doi.org/10.1016/s0960-8966(98)00093-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- An atypical case of partial merosin deficiency congenital muscular dystrophy.Zeitschrift für Neurologie, 1997
- Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin α2 chainNeuromuscular Disorders, 1997
- Transforming Growth Factor-β1 in Polymyositis and Dermatomyositis Correlates with Fibrosis but not with Mononuclear Cell InfiltrateJournal of Neuropathology and Experimental Neurology, 1997
- Mild clinical phenotype in a 12-year-old boy with partial merosin deficiency and central and peripheral nervous system abnormalitiesNeuromuscular Disorders, 1996
- Congenital muscular dystrophyNeurology, 1996
- Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine.JCI Insight, 1995
- The adhesion molecule and cytokine profile of multiple sclerosis lesionsAnnals of Neurology, 1995
- Transforming Growth Factor β in Tissue FibrosisNew England Journal of Medicine, 1994
- Acidic cellular environments: Activation of latent tgf‐β and sensitization of cellular responses to tgf‐β and egfInternational Journal of Cancer, 1989
- Collagen types in neuromuscular diseasesJournal of the Neurological Sciences, 1982